Search Results 111-120 of 183 for ‼토지노추천 【위너보증.com / 가입코드 9122】 어코드 ‼

  1. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  2. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  3. A Study of STX-0712 in Patients with Advanced Hematologic Malignancies - Mayo Clinic

    ... no further treatment options known to confer clinical benefit. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  4. Study to Evaluate the Efficacy and Safety of Ersodetug in Patients With Inadequately Controlled Hypoglycemia Due to Tumor-Associated Hyperinsulinism - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  5. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  6. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  7. Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study ...

  8. Ropeginterferon alfa-2b-njft (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Breastfeeding. There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits ...

  9. A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer - Mayo Clinic

    The purpose of this study is to compare the effectiveness of RO7198457 versus watchful waiting in patients with circulating tumor DNA (ctDNA) positive, ...

  10. Publications - Ajit H. Goenka, M.D. - Mayo Clinic

    2008 Oct; 38(10):109-12. Goenka AH, Kulkarni HS. The Laureate, the Worm, and Rnai; an Interview with Professor Craig Mello, Nobel Prize Winner in Medicine 2006 ...